About Lily MedTech
Lily MedTech is a company based in Tokyo (Japan) founded in 2016. Lily MedTech has raised $3.31 million across 2 funding rounds from investors including Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital. Lily MedTech operates in a competitive market with competitors including OncoStem, PreludeDx, Miltel, POC Medical Systems and Inbiomotion, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.31 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Beyond Next Ventures
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Lily MedTech
Unlock access to complete
Unlock access to complete
Funding Insights of Lily MedTech
Lily MedTech has successfully raised a total of $3.31M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lily MedTech
Lily MedTech has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in AI, energy, and various sectors.
|
Locked | Locked | Locked | |
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Locked | Locked | Locked | |
|
Science and technology research funding and event organization in Japan.
|
Locked | Locked | Locked |
Investor details for Lily MedTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lily MedTech
Investment portfolio details for Lily MedTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lily MedTech
Detailed financials for Lily MedTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lily Medtech Comparisons
Peer comparison for Lily MedTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lily MedTech
Lily MedTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OncoStem, PreludeDx, Miltel, POC Medical Systems and Inbiomotion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| Locked | Locked | Locked |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| Locked | Locked | Locked |
Telomere tests for aging detection and cellular senescence are provided.
|
|
| Locked | Locked | Locked |
Develops rapid tools for breast cancer detection and disease screening worldwide.
|
|
| Locked | Locked | Locked |
Biomarkers for predicting bone metastasis in cancer patients are developed.
|
|
| Locked | Locked | Locked |
uPAR-based PET ligands for breast cancer imaging are developed.
|
Detailed competitors of Lily MedTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lily Medtech
Complete news archive for Lily MedTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lily MedTech
Lily MedTech was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Lily MedTech is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Shiho Azuma is the current CEO of Lily MedTech.
Lily MedTech is a funded company, having raised a total of $3.31M across 2 funding rounds to date.
Lily MedTech was established in 2016 as a venture from the University of Tokyo. Diagnostic imaging equipment utilizing ultrasound technology for breast cancer detection is being developed by the company within the medtech sector. Operations are conducted from Tokyo, Japan, where the focus remains on advancing non-invasive diagnostic solutions. Leadership is provided by CEO Shiho Azuma, with emphasis placed on research and equipment innovation.
Lily MedTech has 4 investors. Key investors include Beyond Next Ventures, Fuyo General Lease, Mitsubishi UFJ Capital, and Japan Science and Technology Agency.